Risk factors for thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study

P Petersen1, J Kastrup, S Helweg-Larsen

  • 1Department of Neurology, University Hospital, Copenhagen, Denmark.

Insights

Previous myocardial infarction is a significant risk factor for thromboembolic complications in chronic atrial fibrillation patients. Other common risk factors like age and hypertension were not found to be significant in this study.

Area of Science:

  • Cardiology
  • Clinical Research

Background:

  • Atrial fibrillation (AF) is a common arrhythmia associated with increased risk of thromboembolic complications.
  • Understanding cardiovascular risk factors is crucial for managing AF patients and preventing stroke.

Purpose of the Study:

  • To evaluate the association between cardiovascular risk factors and the development of thromboembolic complications in patients with chronic atrial fibrillation.
  • To identify significant predictors of thromboembolic events in the placebo group of the Copenhagen AFASAK study.

Main Methods:

  • Analysis of data from 336 patients in the placebo group of the Copenhagen AFASAK study.
  • Utilized Cox's regression model to assess the statistical importance of various cardiovascular risk factors.
  • Included baseline assessments such as physical examination, chest roentgenogram, and echocardiogram for left atrial size determination.

Main Results:

  • Previous myocardial infarction was identified as a statistically significant risk factor for thromboembolic complications.
  • Factors including age, gender, heart failure, hypertension, diabetes, blood pressure, smoking, heart volume, and left atrial size were not statistically significant.

Conclusions:

  • Previous myocardial infarction is a key predictor of thromboembolic complications in chronic atrial fibrillation.
  • The study highlights the importance of considering a history of myocardial infarction in risk stratification for AF patients.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...